Risk Prediction of Carotid Endarterectomy by Vascular Ultrasound Evaluation
Completed
- Conditions
- Stroke
- First Posted Date
- 2018-12-24
- Last Posted Date
- 2022-07-18
- Lead Sponsor
- Xuanwu Hospital, Beijing
- Target Recruit Count
- 1498
- Registration Number
- NCT03785626
- Locations
- 🇨🇳
Xuanwu Hospital, Capital Medical University, Beijing, Beijing, China
DCB Compared Stenting in Popliteal Lesions
Not Applicable
- Conditions
- Popliteal StenosisDiabetesPopliteal Artery Occlusion
- Interventions
- Device: DCB angioplasty (Orchid, Acotec Scientific Co. Ltd.)Device: Stent (Maris,Medtronic.USA or Sinus/Supera, Germany)
- First Posted Date
- 2018-11-14
- Last Posted Date
- 2018-11-14
- Lead Sponsor
- Xuanwu Hospital, Beijing
- Target Recruit Count
- 80
- Registration Number
- NCT03739580
- Locations
- 🇨🇳
Gu Yong Quan, Beijing, Beijing, China
Endarterectomy vs Stenting in Chinese Asymptomatic Carotid Stenosis Patients
Not Applicable
- Conditions
- Carotid Stenosis
- Interventions
- Procedure: Carotid EndarterectomyProcedure: Carotid Artery Stenting
- First Posted Date
- 2018-11-09
- Last Posted Date
- 2018-11-09
- Lead Sponsor
- Xuanwu Hospital, Beijing
- Target Recruit Count
- 600
- Registration Number
- NCT03737175
- Locations
- 🇨🇳
Shanghai Changhai Hospital, Shanghai, China
🇨🇳Sino-Japanese Friendship Hospital, Beijing, China
🇨🇳Zhongshan Hospital affiliated to Fudan University, Shanghai, China
Bare-metal Stent vs Covered Stent in Chinese Patients With Subclavian Occlusive Lesions
Not Applicable
- Conditions
- Subclavian Occlusion
- Interventions
- Procedure: Stent implantation of subclavian artery
- First Posted Date
- 2018-11-09
- Last Posted Date
- 2018-11-09
- Lead Sponsor
- Xuanwu Hospital, Beijing
- Target Recruit Count
- 408
- Registration Number
- NCT03737162
- Locations
- 🇨🇳
Shanghai Changhai Hospital, Shanghai, China
🇨🇳The first affiliated Hospital of Dalian Medical University, Dalian, China
🇨🇳Shanghai Changzheng Hospital, Shanghai, China
Molecular Mechanisms of Malignant Cerebral Edema After LHI
- Conditions
- Cerebral Edema
- Interventions
- Other: Treatments to reduce intracranial pressure
- First Posted Date
- 2018-10-11
- Last Posted Date
- 2020-03-03
- Lead Sponsor
- Xuanwu Hospital, Beijing
- Target Recruit Count
- 120
- Registration Number
- NCT03703284
- Locations
- 🇨🇳
Xuanwu Hospital of Capital Medical University, Beijing, China
The Influence of Mandibular Advancement Device Treating OSAHS on Primary Prevention of Ischemic Stroke
Not Applicable
Completed
- Conditions
- Sleep Apnea SyndromesAtherosclerosisCarotid Plaque
- Interventions
- Device: oral appliance treatment
- First Posted Date
- 2018-09-11
- Last Posted Date
- 2020-07-22
- Lead Sponsor
- Xuanwu Hospital, Beijing
- Target Recruit Count
- 100
- Registration Number
- NCT03665818
Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells
Phase 1
- Conditions
- Pancreatic CancerOvarian CancerColon CancerLung CancerBreast Cancer
- Interventions
- Biological: Activated NK
- First Posted Date
- 2018-08-16
- Last Posted Date
- 2019-01-11
- Lead Sponsor
- Xuanwu Hospital, Beijing
- Target Recruit Count
- 200
- Registration Number
- NCT03634501
- Locations
- 🇨🇳
Xuanwu Hospital, Beijing, Beijing, China
Effects of Lingzhi on Disease Progression in Patients With Untreated Early Parkinson's Disease
Phase 3
- Conditions
- Parkinson Disease
- Interventions
- Drug: GanodermaDrug: Placebos
- First Posted Date
- 2018-07-20
- Last Posted Date
- 2021-08-26
- Lead Sponsor
- Xuanwu Hospital, Beijing
- Target Recruit Count
- 288
- Registration Number
- NCT03594656
- Locations
- 🇨🇳
Xuanwu Hospital of Capital Medical University, Beijing, Beijing, China
CPI Combination Therapy for Autoimmune Encephalitis
Not Applicable
Completed
- Conditions
- Autoimmune Encephalitis
- Interventions
- Procedure: Plasma exchange (PE)
- First Posted Date
- 2018-05-31
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- Xuanwu Hospital, Beijing
- Target Recruit Count
- 70
- Registration Number
- NCT03542279
- Locations
- 🇨🇳
Xuanwu Hospital of Capital Medical University, Beijing, Beijing, China
TCD Monitoring Technology Guides the Precise Control of Blood Pressure After EVT
Phase 4
- Conditions
- Acute Ischemic Stroke
- Interventions
- Combination Product: Urapidil Hydrochloride Injection
- First Posted Date
- 2018-05-18
- Last Posted Date
- 2018-05-18
- Lead Sponsor
- Xuanwu Hospital, Beijing
- Target Recruit Count
- 90
- Registration Number
- NCT03529149
- Locations
- 🇨🇳
Xuanwu Hospital, Beijing, Beijing, China